scorecardresearch
Zydus seeks emergency approval for 'needle-free' three-dose COVID-19 vaccine for children above 12

Zydus seeks emergency approval for 'needle-free' three-dose COVID-19 vaccine for children above 12

If the Subject Expert Committee finds the phase-3 trial data and documents submitted by Cadila satisfactory, emergency use approval will be granted for the vaccine this week itself

Zydus Cadila's jab is a three-dose, intradermal vaccine which is administered using the PharmaJet needle-free system Zydus Cadila's jab is a three-dose, intradermal vaccine which is administered using the PharmaJet needle-free system

Drugs Controller General of India (DCGI) will consider granting emergency use approval for Zydus Cadila's COVID-19 vaccine-ZyCov-D for children above 12. This vaccine has been tested on children above 12 as well as adults.

The Subject Expert Committee (SEC) will examine the data submitted by the pharma major. If the committee finds the phase-3 trial data and documents submitted by Cadila satisfactory, emergency use approval will be granted for the vaccine this week itself.

"The preliminary assessment of the application submitted by the company is going on and we have sent it to the SEC for further consideration. The SEC will be meeting in the coming week, representatives of the company will be also asked to make presentations," an official told The Times of India.

Also read: COVID-19: India's current vaccination rate 'not good enough', says Arvind Panagariya

ZyCov-D has already shown strong immunogenicity and tolerability and safety profile in phase 1 and phase 2 trials. Once approved, the vaccine supply is likely to begin in August-September and ZyCov-D will be the fifth vaccine against coronavirus to get approved in India.

Zydus Cadila's jab is a three-dose, intradermal vaccine which is administered using the PharmaJet needle-free system. It does not need very low storage temperatures and can be stored at 2-8 degree Celsius. This, in turn, will lead to glitch-free transportation and storage and reduce any chances of vaccine wastage.

Edited by Mehak Agarwal

Also read: COVID-19: Israel to begin giving third shot of Pfizer vaccine to adults at risk